Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

60%

6 trials in Phase 3/4

Results Transparency

88%

7 of 8 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

Phase 3
4(44.4%)
Phase 4
2(22.2%)
Phase 2
2(22.2%)
Early Phase 1
1(11.1%)
9Total
Phase 3(4)
Phase 4(2)
Phase 2(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT02355665Phase 3Completed

Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy

Role: lead

NCT01500629Early Phase 1Completed

Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever

Role: lead

NCT02209181Phase 2Completed

A Dental Pain Study to Test the Effectiveness of a New Pain Reliever Medicine

Role: lead

NCT01744106Phase 3Completed

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Role: collaborator

NCT01794728Completed

How the Elderly Live With Pain in Heart Failure

Role: collaborator

NCT01960114Phase 2Completed

Study of Long-Acting Acetaminophen in Postoperative Dental Pain

Role: lead

NCT01781507Phase 4Completed

Study of Bronchodilation Effects of Cetirizine

Role: collaborator

NCT01257542Phase 4Terminated

Acute Cough Study In Children

Role: collaborator

NCT01115673Phase 3Completed

To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery

Role: lead

NCT01296698Phase 3Terminated

Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking

Role: lead

All 10 trials loaded